Table 1. Number of individuals in this study.
| Population | Japanese | Korean | Hong Kong | Thai |
| Total number of samples | 1,291 | 586 | 661 | 629 |
| HBV patients | 489 | 340 | 281 | 390 |
| IC | 114 | - | - | - |
| CH | 147 | 175 | 187 | 198 |
| AE | 21 | - | - | - |
| LC | 38 | - | - | - |
| HCC | 169 | 165 | 94 | 192 |
| Mean age (y) | 57.1 | 44.7 | 57.9 | 52.0 |
| (min-max) | (20–84) | (18–74) | (32–86) | (21–84) |
| Gender (M/F) | 338/151 | 265/75 | 239/42 | 289/101 |
| Resolved individuals* | 335 | 106 | 190 | 113 |
| HCV (−) | 249 | 106 | 190 | 113 |
| HCV (+) | 86 | - | - | - |
| Mean age (y) | 59.7 | 43.1 | 40.0 | 48.2 |
| (min-max) | (18–87) | (12–66) | (18–60) | (39–66) |
| Gender (M/F) | 173/162 | 61/45 | 113/77 | 83/30 |
| Healthy controls | 467 | 140 | 190 | 126 |
| Mean age (y) | 39.0** | 33.7 | 26.2 | 46.6 |
| (min-max) | (23–64) | (1–59) | (16–60) | (38–79) |
| Gender (M/F) | 370/97 | 67/73 | 87/103 | 73/53 |
Abbreviation: IC, Inactive Carrier; CH, Chronic Hepatitis; AE, Acute Exacerbation; LC, Liver Cirrhosis; HCC, Hepatocellular Carcinoma.
* Resolved individuals were HBsAg negative and HBcAb positive.
** 419 of 467 healthy controls were de-identified, without information on age.